Integrative Cancer Care approach
“GUIDED BY SCIENCE, TAILORED FOR YOU”
We combine advanced medical technologies with compassionate patient care to deliver comprehensive, evidence-based treatment plans tailored to your needs. Our approach integrates conventional therapies, such as chemotherapy, with more innovative treatments like immunotherapies to ensure the most effective and personalised care. By blending the latest advancements in medical science with a patient-centred philosophy, we aim to address every aspect of your well-being. This holistic approach ensures that your treatment not only targets the disease but also supports your overall recovery and long-term health.
Precision chemotherapy
Precision chemotherapy treatment involves tailoring cancer chemotherapy based on the genetic profile of the tumour and the individual patient. This approach aims to maximise the efficacy of the drugs while minimising side effects. Key components include:
Genomic Testing
Analysing the tumour’s genetic mutations to select the most effective chemotherapy agents.
Biomarker Identification
Identifying specific biomarkers that predict a patient’s response to certain drugs.
Targeted Drug Delivery
Using nanoparticles or other methods to deliver drugs directly to cancer cells, reducing impact on healthy cells.
Personalized Dosing
Adjusting drug dosages based on the patient’s metabolism and genetic factors to optimise effectiveness and reduce toxicity.
This personalised approach enhances treatment outcomes and improves the quality of life for patients.
Targeted Therapies
Targeted therapy is a cancer treatment that uses drugs designed to specifically identify and attack cancer cells while sparing normal cells. Key features include Molecular Targeting, Monoclonal Antibodies and Small Molecule Inhibitors. By focusing on cancer-specific pathways, targeted therapy aims to be more effective and cause fewer side effects than traditional chemotherapy.
Cell-based therapy
Cell-based therapy in cancer involves using living cells to treat the disease, focusing on harnessing the body’s immune system or other cellular mechanisms. Key approaches include:
Natural Killer Cell (NK Cell) Therapy
is a cutting-edge cancer treatment that harnesses the body’s immune system to target and destroy cancer cells. By enhancing the activity of NK cells—key immune cells known for their ability to recognise and eliminate abnormal cells—this therapy offers a precise, effective, and minimally invasive approach to fighting cancer.
Dendritic Cell Vaccines
Dendritic cell (DC) vaccines are a form of personalised immunotherapy that harnesses the power of dendritic cells to stimulate the immune system against cancer. These vaccines are created by isolating a patient’s dendritic cells, exposing them to cancer antigens, and reintroducing them into the body to activate T-cells. This targeted approach enhances the immune response, helping the body recognise and attack cancer cells more effectively.
Personalized neoantigen vaccine
Neoantigen cancer vaccines are a cutting-edge form of personalised immunotherapy designed to target unique mutations, known as neoantigens, that are specific to an individual’s tumour. These neoantigens arise from genetic changes in cancer cells and are absent in normal tissues, making them ideal targets for a highly specific immune response.
By introducing synthetic versions of these neoantigens into the body, the vaccine stimulates the immune system, particularly T-cells, to recognise and attack tumour cells displaying these unique markers. This approach offers a precise, customised treatment that enhances the immune system’s ability to combat cancer while minimising off-target effects on healthy tissues.
Stem Cell Transplants
Hematopoietic stem cells are used to replenish the bone marrow after high-dose chemotherapy or radiation, which is often used to treat blood cancers.
These therapies aim to enhance the body’s natural ability to fight cancer, offering personalised and potentially more effective treatment options.
Immunotherapy
Immunotherapy using checkpoint inhibitors is a cancer treatment that helps the immune system recognise and attack cancer cells. Key points include:
Immune Checkpoints
These are regulatory pathways in the immune system that prevent excessive immune responses and autoimmunity.
Checkpoint Inhibitors
Drugs that block checkpoint proteins, such as PD-1, PD-L1, and CTLA-4, which cancer cells exploit to avoid being attacked by the immune system.
Mechanism
By inhibiting these checkpoints, the drugs unleash T cells to attack and destroy cancer cells more effectively.
Checkpoint inhibitors have shown significant success in treating various cancers, including melanoma, lung cancer, and others, by enhancing the body’s natural immune response against tumours.
Examples: Common checkpoint inhibitors include pembrolizumab (Keytruda), nivolumab (Opdivo), and ipilimumab (Yervoy).
Contact us today to schedule a consultation and take the first step
toward lasting recovery and well-being.